IP Verse

Hetero Labs Limited competitive analysis

Explore patent oppositions filed by Hetero Labs Limited against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026

Patent Number	Title	Applicant	Opposition Date
EP3133070	Eliglustat (Genz 112638) As Inhibitor Of Glucosylceramide Synthase For Use In A Method Of Treating Fabry'S Or Gaucher'S Disease, The Method Comprising Adjusting The Individual Therapeutical Dose To The P-450 Metabolism Of The Patient	GENZYME	May 14, 2020

Discover the latest PTAB cases involving Hetero Labs Limited, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Hetero Labs Limited with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
HETERO LABS LIMITED	1	-	-	-
GENZYME	1	29	2	11